A Pre and Post Test Intervention Design to Prevent Abortion and Contraceptive-use Stigma Among School Youths in Kenya (SAC)

March 13, 2021 updated by: Marlene Makenzius, Karolinska Institutet

A Pre and Post Test Intervention Program to Prevent Abortion and Contraceptive-use Stigma Among School Youths in Kenya: A Quasi-Experimental Design

In many low-income countries, unsafe abortion is recognized as a leading cause of maternal morbidity and mortality. Social stigma surrounding abortion and contraceptive use plays a critical role in the social, medical, and legal marginalization of abortion and contraceptive services. Though this stigma is pervasive and threatens women's health, it is not well understood how it can be reduced. The Stigmatizing Attitudes, Beliefs and Actions Scale (SABAS) was designed in 2013, to measure abortion stigma at individual and community level. Objective: I) to conceptualize abortion stigma among; health care providers, secondary school teachers and students, and II) to determine if a school based intervention targeting stigma specifically faced by girls when accessing abortion and contraceptive services, compared to usual standards, will decrease related stigma and increase contraceptive use among students, who are sexually active. Design, Setting, Participants: I) Focus group discussions (FGD) with service providers at YFC (n=12), secondary school teachers (n=16) and secondary school students (n=20), and II) a quasi-experimental pre- and post-intervention study, targeting 800 secondary school students (14-20 y), in Kisumu, Kenya. Two schools will be assigned; one interventions unit (n=400 students) and one control unit (n=400 students). The schools are similar according to the study site, size and academic standards. The region is chosen because of its low rate of contraceptive use, and high rate of teen pregnancy and of unsafe abortions. Standard deviation is the measure of dispersion or variability in the data. The sample size of 400 is based on a previous study and will give a power of 80% to detect differences (95% Cl) between the two groups. Intervention: An abortion- and contraceptive-use stigma reduction intervention (1-month program), capturing negative stereotypes about women that are associated with abortion and contraceptive use. Main Outcome: Abortion-stigma reduction. Secondary outcome: Contraceptive-use stigma reduction. Measured at baseline (pre-test), and post-test at 1- and 12-months, by using the validated SABA-scale. Analyses: Qualitative content analysis and repeated measures, ANOVA.

Funded by: The Swedish Research Council for Health, Working Life and Welfare 2015-01194, and The Swedish Research Council 2016-05670

Study Overview

Detailed Description

Today, abortion is one of the most common practices within gynaecological care. Despite its existence across time and its persistence across geographic location, the impact of abortion on women, families, communities and societies differs a lot across the world. Safe abortions - done by trained providers in hygienic settings and particularly early medical abortions carry fewer health risks. In countries like Sweden, Romania, Nepal and South Africa, liberalisation of abortion laws has had a direct and positive impact on maternal mortality. Yet, approximately half of the 42 million abortions that take place every year are unsafe. Nearly one in five maternal deaths can be attributed to unsafe abortion, and more than 500 women per 100,000 live births die from consequences of unsafe abortions. There is an inherent need to invest in intervention strategies to improve maternal health, especially amongst youth.

Until recently, abortion was only legally permissible in Kenya to save the life of a woman, but a new constitution adopted in 2010 makes abortion available to protect a woman's health. Article 43 in the constitution further widens access to reproductive health rights, as every person has the right to the highest attainable standard of health, which includes the right to health care services, including reproductive health care. However, contraceptive use remains low in Kenya. Consequently unwanted pregnancy and unsafe abortions are common, many of which require medical care for complications. A Kenyan woman has a one in 55 chance of dying from pregnancy related causes over her lifetime, and about 360 women per 100,000 live births die.

Sexuality education is part of general education. Its preventive nature not only contributes to the prevention of negative consequences linked to sexuality, but can also improve quality of life, health and well-being. In this way, sexuality education contributes to health promotion in general. In some countries SRE in school is compulsory, as for example in Sweden. In Kenya, SRE is not compulsory in the teacher education. Many teachers receive additional training, although this training has a focus on teaching about HIV/AIDS. Oginga (2014) recommend that SRE need to be incorporated and compulsory in the teacher-training curriculum in Kenya.

While extensive research has investigated the public health consequences of unwanted pregnancy and unsafe abortion from a human rights perspective, there is little research on stigma related to contraceptive use and abortion among youths. Causes of abortion stigma such as negative gender stereotypes, intent to control female sexuality, compulsory motherhood - are social constructs that can be deconstructed. Women's subordinate status in most societies has negative implications for women's sexual and reproductive health and rights (SRHR).

Although there is lack of research on stigma related to contraceptive use and abortion and how it can be reduced, the occurrence of such stigma are widely acknowledged in many countries. Few conceptual and methodological tools exist to measure its effects. For many years now, the International Planned Parenthood Federation (IPPF), together with partner organizations, has implemented programmes to specifically address and combatting HIV stigma. In the past five years there has been increased global attention on abortion stigma. IPPF has thus expanded its work to address the impact that negative beliefs and attitudes about abortion has on access to, and scale-up of, safe abortion services. Abortion stigma manifests at many levels, from individuals and service providers to communities, institutions, laws and policies, and wider public discourse including the media.

In 2013, Ipas developed a scale to measure abortion stigma at the individual and community levels, the Stigmatizing Attitudes, Beliefs and Actions Scale (SABAS), to inform the development of interventions to mitigate stigma.

PROJECT DESCRIPTION Purpose and Aims

This project has mixed-methods approach, a qualitative and quantitative quasi-experimental pre- and post-intervention design. The purpose is to empirically determine what role stigma related to abortion and contraceptive use plays, how it is expressed, and how it can be countered most effectively.

Firstly, the aim is to conceptualize abortion stigma, among health care providers in YFC, and among teachers and students in secondary schools. Secondly, to determine if a school based intervention, compared to usual standards, will decrease abortion- and contraceptive-use stigma and increase contraceptive use among sexually active secondary school students.

METHODOLOGY The social and political sensitivity surrounding induced abortion makes it very difficult to conduct high-quality research to measure its incidence and related stigma, which automatically introduces bias into the result. Surveys of providers are also problematic for a number of reasons, as for example in countries where safe abortion is illegal for obvious reasons (fear of prosecution). Therefore the investigators have chosen to use qualitative- and quantitative approaches (data triangulation) to conceptualize abortion and contraceptive use stigma, and to estimate and validate the incidence.

Design: I) a qualitative approach with Focus Group Discussions (FGDs), and II) a quantitative quasi-experimental pre- and post-intervention study design, comparing student attitudes in intervention schools and matched control schools will be used. Tool: SABA-scale will be used to assess attitudes and behaviour at baseline (pre-test) and post-test at 1 and 12 month. Primary out outcome: Abortion-stigma. Secondary outcome: Contraceptive-use stigma.

Settings: Potential schools in semi-urban settlements in the county of Kisumu, will be identified according to the study site, size and academic standards (public schools). The schools will be ordered alphabetically by name and imported into a statistical computer software by an IT-assistant at Kisumu Medical and Educational Trust (KMET), Kisumu. The software will randomly generate the allocation schedule for assignment of the stigma reduction intervention to one school, and one to be operated as a control school. This area has a dominance of Christian religions, Luo, Luhya and Kisii ethnic groups, and low socio-economic status (SES) reflect the regional profile.

Participants: I) Service providers (n=12) in YFC, secondary school teachers (n=16) and will participate in gender mixed FGDs, and students (females, n=10; males, n=10), and II) secondary school students between 14 and 20 years (n=200 male students; 200 female students), will be included in the intervention unit, and the about the same number in the control unit.

Measurements: The Stigmatizing Attitudes, Beliefs and Actions Scale (SABAS) is a tool designed to measure abortion stigma at the individual and community level. A 57-item instrument was created in 2013, pre-tested, and administered to 531 individuals (n=250 in Ghana and n=281 in Zambia). All analyses were completed using Stata IC/11.2. SABAS captures three important dimensions of abortion stigma: negative stereotypes (8 items), discrimination and exclusion (7 items), and potential contagion (3 items) (1). IPPF adapted the Stigmatising Attitude, Beliefs and Actions Scale (SABAS) developed by Ipas to measure abortion stigma amongst community members in the project areas in Benin, Burkina Faso, India and Pakistan at the outset and end of the Packard Foundation abortion stigma project 2014-2016. The response categories in SABAS have a Likert format from "strongly disagree" to "strongly agree" with each response being assigned a value ranging from 1-5. The tool can be used in several ways: for example as baseline and/or endline data collection in stigma-reduction interventions or as a "pre and post-test" to measure short-term change at the individual and/or community level. The SABA tool will be further modified to adapt the tool to the context of this setting. In addition new questions will be drafted targeting gender stereotypes related to girls and contraceptive-use and misconceptions (including condom use) at last sexual intercourse (yes/no). These questions will be drafted in collaboration with providers, teachers and students, study I (FGD). This adapted tool will be used at baseline (pre-test) and post-test at 1 and 12 months, to measure short- and long-term change at both group- and individual level.

Analysis and sample size calculation: Study I) data will be qualitatively analysed according to guide for exploring contraceptive- and abortion-related stigma. Study II). The sample size will take into account to identify a 25% stigma reduction (one-sided t-test), using a 95% CI (α=0.05). The sample size was preliminary calculated to be about 1,200 and arbitrarily derived since the 2 schools were drawn from a regional sample frame of four gender-mixed christian schools with a minimum of 400 students (similar schools according to study site, SES, and academic standards). However, for the initial validation of the scales the sample size (n = 300/school) was based on the principle of a minimum of ten respondents (5/gender) per scale item, and with a drop-out rate of 20%, and a further loss to follow-up of the final-year students who participated in the intervention but were not planned to be followed up at one-year, as they will have left the school (~30%).

The outcome of the intervention will be analysed quantitatively according to Shellenberg et al (2013). A higher score on the SABAS represents more stigmatizing attitudes and beliefs. There is no predetermined cut-off or threshold for what represents stigma. The results will guide us if to use the scores as continuous variables or to create cut-offs that are appropriate to the context/setting. For continuous variables, the intervention effect are to be analyzed using repeated measures ANOVA (PASW 20.0), significant p-value >0.05. Within-subjects factor: time. Between-subjects factor: intervention vs. control. Dependent variable: SABAS attitudes, beliefs and actions items.

ETHICAL CONSIDERATIONS Ethical clearance is recieved from JOOTRH/CDC in Kisumu, research and ethics authority who will review the proposal for approval before the project starts. All participants will be asked to give a written consent. For participants who are below 18 years, we will obtain parental consent as well as approval from the Ministry of education. Consent forms will be translated into Kiswahili language and back translated into English to ensure accurate translation. The participants will be informed that they can withdraw from participation at any time without any consequences. The research team will ensure that all research data, regardless of format, is stored securely and backed up or copied regularly. All data will be handled according to national laws and guidelines. Prof Edwin Were, a research team member is also a member in a regional ethical committee, and he will overview the ethical aspects in this study, in accordance to national laws and guidelines.

PROJECT TEAM AND COLLABORATORS Professor Kristina Gemzell-Danielsson, Karolinska University Hospital, head of the research group at the WHO-collaborating centre at the department of Obstetrics and Gynaecology, Karolinska Institutet has extensive experiences from conducting international randomised control trials within Human Reproduction. Professor Elisabeth Faxelid, Karolinska Institutet and Associated professor Marie Klingberg-Allvin, Högskolan Dalarna has long experiences of international intervention- and facility-based research. The applicant, Marlene Makenzius, has previous experiences from research related to induced abortion among Swedish women and men (Uppsala University), Public Health Policy analyses at a national level (The National Agency of Public Health, Sweden), practical work as midwife at YFC and have currently monitored a post-abortion care project in Kisumu (RCT-study).

The following Kenyan researchers will be involved in the project: Monica Oguttu, PhD RNM, Head of KMET, Sam Owoko, Program manager at KMET, currently involved in a male-involvement project and a STI/HIV-intervention in primary schools, Dr. Paul Mitei Obs/Gyn practitioner and traiinig expert with vast experience and also involved in PAC study, currently KCH Obs/Gyn. Caroline Nyandat, Midwife/nurse, Coordinator at KMET, currently involved quality development in a YFC, Edwin Were, is professor of Reproductive Health at Moi University in Eldoret, with long experience in clinical service provision and managing clinical trials and also serves in a local ethics committee. Theresa Mary Awuor, nurse midwife, BscN, a PhD student, experience in leadership currently a member of the Technical working Group-Global Health Leadership with a consortium of universities in the United States of America and African Universities called Afya Bora, and Beatrice Otieno, data clerk at KMET.

PRINCIPLE INVESTIGATORS Marlene Makenzius from Sweden and Monica Oguttu from Kenya.

SIGNIFICANCE IN KENYA The complications from unsafe abortion continue to pose a serious threat to Kenyan women's health. Nearly 120,000 women received care in health facilities for complications resulting from unsafe abortions in 2012, corresponding to an induced abortion ratio of 30 abortions per 100 births in 2012. Severe complications of unsafe abortions were most common among women aged 10-19. More than 70% of women seeking post-abortion care were not using a method of contraception prior to becoming pregnant. The investigators believe that the potential benefit of this study is high on a community level as well as the individual level. The participants may also benefit as the intervention targets contraceptive use and may thus reduce unwanted pregnancy. Unwanted pregnancy undermines young peoples' (especially women's) schooling, health, social status and future opportunities for work. Young people will therefore benefit from reduced abortion-stigma and increased contraceptive use. In addition, in Kisumu this study will

  • Encourage SRH as part of the regular curriculum in secondary schools.
  • Encourage male involvement in health-seeking practices and women's reproductive health.
  • Increase access to contraceptive-use among students .
  • Identify and empower representatives from the communities; school- and church leaders, and open meetings for publics (Baraza), to sensitize and influence communities on problems of unsafe abortion and low contraceptive use.
  • Establishment of environments and capacity among international, national and regional research actors and leading NGO's to mitigate the gap between knowledge and practice in the prevention of unsafe abortions.
  • Enable women within the project to undergo research training that will facilitate development of local and regional academic competence.
  • Create awareness of gender equality perspective in research.

Study Type

Interventional

Enrollment (Actual)

1207

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kisumu County
      • Kisumu, Kisumu County, Kenya
        • Secondary schools in Kisumu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Secondary school students between 14 and 20 years

Exclusion Criteria:

  • Age below 14 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Abortion- and contraceptive-use stigma reduction program
Four sessions (à 120 min), every week in 1 month.

An abortion- and contraceptive-use stigma reduction intervention (3-weeks), capturing i. Negative stereotypes associated with girls who have had an abortion. ii. Discrimination/exclusion of girls who have had an abortion. iii. Fear of coming in contact with a girls who have had an abortion. iv. Negative stereotypes about girls using a contraceptive method. v. Misconceptions about contraceptive use.

The pedagogy will be based on that gender stereotypes, intent to control female sexuality, compulsory motherhood, are social constructs that can be deconstructed. Pedagogical methods will include role modelling, practice of desired behaviours, activities for building self-efficacy, and didactic instructions.

Other Names:
  • SAC - Stigma Abortion Contraception
Active Comparator: Usual standards
Usual standards according to the school curriculum in Kenya.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stigmatizing attitudes associated with girls who have had an abortion: To assess a reduction from baseline attitudes at 12 months
Time Frame: Baseline, and post-test at 12 months
Measured with the SABA-scale
Baseline, and post-test at 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stigmatizing attitudes associated with girls using a contraceptive method: To assess a reduction from baseline attitudes at 12 months
Time Frame: baseline, and post-test at 12 month
Measured with a questionnaire (likert scale)
baseline, and post-test at 12 month
Stigmatizing attitudes associated with girls who have had an abortion: To assess a reduction from baseline attitudes at 1 month
Time Frame: baseline, and post-test at 1 month
Measured with the SABA-scale
baseline, and post-test at 1 month
Stigmatizing attitudes associated with girls using a contraceptive method: To assess a reduction from baseline attitudes at 1 month
Time Frame: baseline, and post-test at 1 month
Measured with a questionnaire (likert scale)
baseline, and post-test at 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marlene Makenzius, PhD, Karolinska Institutet
  • Principal Investigator: Monica Oguttu, PhD, Kisumu Medical Education Trust, Kenya

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 5, 2017

Primary Completion (Actual)

February 28, 2018

Study Completion (Actual)

March 5, 2018

Study Registration Dates

First Submitted

February 17, 2017

First Submitted That Met QC Criteria

February 22, 2017

First Posted (Actual)

February 28, 2017

Study Record Updates

Last Update Posted (Actual)

March 17, 2021

Last Update Submitted That Met QC Criteria

March 13, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 4-3163/2015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Abortion- and contraceptive-use stigma reduction program

3
Subscribe